From Name:
From Email:
To Name:
To Email:

Optional Message:

Herbst highlights next steps with immunotherapy in lung cancer

from OncLive

Immunotherapy has garnered major traction as a treatment approach for patients with lung cancer, but there are still several unanswered questions that need to be addressed in this space, according to Roy S. Herbst, MD, PhD. Because only a small percentage of this patient population benefits from immunotherapy, ongoing work is being geared toward acquiring a stronger understanding on the different mechanisms of resistance to this approach. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063